The latest antibody study from ONS (to 20th Feb) shows little change, with very high levels at all ages, and no signs of the waning in older ages we saw after the second dose.
— John Roberts (@john_actuary) March 9, 2022
1/https://t.co/sem2hlyqI4 pic.twitter.com/SjGNhk7O5x
Share:
- Click to share on Facebook (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on Twitter (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on Skype (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- Click to email a link to a friend (Opens in new window)
